DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of July 2, 2016 and December 31, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.

Interest Rate Swaps and Treasury Locks

Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.

During the six months ended December 31, 2015, we entered into a forward interest rate swap to hedge against changes in the benchmark interest rate between the date the interest rate swap was entered into and the date of expected future debt issuance. The interest rate swap was designated as a cash flow hedge and had a notional amount totaling $200.0 million. The interest rate swap was settled upon the issuance of an aggregate $1.2 billion principal amount of senior notes on March 7, 2016 for a cumulative after-tax loss of $7.0 million in OCI during the six months ended July 2, 2016.

In connection with the Omega acquisition, we assumed a $20.0 million private placement note. We also assumed an interest rate swap agreement with a notional amount totaling $20.0 million that was in place to hedge the cross currency exchange differences between the U.S. dollar and the euro on the above-mentioned debt. On May 29, 2015, we repaid the loan and the interest rate swap. We also assumed €500.0 million ($544.5 million) of debt under Omega's revolving credit facility, as well as an interest rate swap agreement with a notional amount of €135.0 million ($147.0 million) that was in place to hedge the change in the floating rate on that credit facility. On April 8, 2015, we repaid the loan and terminated the interest rate swap. Because both interest rate swaps mentioned above were recorded at fair market value on the date of termination, no gain or loss was recorded. For more information on the acquired debt and termination, see Note 10.

During the three months ended June 27, 2015, we repaid a $300.0 million term loan with floating interest rates priced off the LIBOR yield curve, see Note 10. As a result of the term loan repayment on June 25, 2015, the forward interest rate swap agreements with notional amounts totaling $240.0 million that were in place to hedge the change in the LIBOR rate were terminated as well. We recorded a loss of $3.6 million in Other expense, net, during the three months ended June 27, 2015 for the amount remaining in Accumulated Other Comprehensive Income (Loss) ("AOCI") when the hedges were terminated.

Foreign Currency Derivatives

We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables, and future royalties denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of 15 months. The total notional amount for these contracts was $500.4 million and $755.5 million as of July 2, 2016 and December 31, 2015, respectively.

In order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price of Omega, we entered into non-designated forward contracts that matured during the three months ended March 28, 2015. We recorded losses of $259.8 million during the three months ended March 28, 2015 related to the settlement of the forward contracts in Other expense, net. The losses on the derivatives due to changes in the euro-to-U.S. dollar exchange rates were economically offset at closing in the final settlement of the euro-denominated Omega purchase price. In June 2015, in order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated GSK Products acquisition discussed in Note 2, we entered into a non-designated option contract to protect against a strengthening of the euro relative to the U.S. dollar. We recorded losses of $1.9 million for the change in fair value of the option contract during the three months ended June 27, 2015 in Other expense, net. Because these derivatives were economically hedging future acquisitions, the cash outflows associated with their settlement are shown as investing activity on the Condensed Consolidated Statements of Cash Flows.

Effects of Derivatives on the Financial Statements

The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:



	Asset Derivatives
	Balance Sheet Location	Fair Value
		July 2, 2016		December 31, 2015
Designated derivatives:
Foreign currency forward contracts	Other current assets	$	2.6	$	3.8
Total designated derivatives		$	2.6	$	3.8
Non-designated derivatives:
Foreign currency forward contracts	Other current assets	$	1.7	$	1.0
Total non-designated derivatives		$	1.7	$	1.0



	Liability Derivatives
	Balance Sheet Location	Fair Value
		July 2, 2016		December 31, 2015
Designated derivatives:
Foreign currency forward contracts	Accrued liabilities	$	1.0	$	2.0
Interest rate swap agreements	Other non-current liabilities	—		0.3
Total designated derivatives		$	1.0	$	2.3
Non-designated derivatives:
Foreign currency forward contracts	Accrued liabilities	$	1.8	$	1.9
Total non-designated derivatives		$	1.8	$	1.9

The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:



	Amount of Gain/(Loss) Recorded in OCI (Effective Portion)
	Three Months Ended						Six Months Ended
Designated Cash Flow Hedges	July 2, 2016			June 27, 2015			July 2, 2016			June 27, 2015
Interest rate swap agreements	$	—		$	(14.0	)	$	(9.0	)	$	(12.0	)
Foreign currency forward contracts	(0.3		)	2.7			1.3			(1.1		)
Total	$	(0.3	)	$	(11.3	)	$	(7.7	)	$	(13.1	)

The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:



		Amount of Gain/(Loss) Reclassified from AOCI to Income (Effective Portion)
		Three Months Ended						Six Months Ended
Designated Cash Flow Hedges	Income Statement Location	July 2, 2016			June 27, 2015			July 2, 2016			June 27, 2015
Treasury locks	Interest expense, net	$	—		$	(0.1	)	$	—		$	(0.1	)
Interest rate swap agreements	Interest expense, net	(0.6		)	(19.1		)	(1.1		)	(18.2		)
Foreign currency forward contracts	Net sales (restated)	(0.1		)	2.7			0.4			1.8
	Cost of sales	0.6			(1.8		)	0.9			(4.6		)
	Interest expense, net	(0.6		)	—			(0.9		)	—
	Other expense, net (restated)	1.7			(0.9		)	1.9			(0.4		)
Total		$	1.0		$	(19.2	)	$	1.2		$	(21.5	)

The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a $1.0 million loss.

The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:



		Amount of Gain/(Loss) Recognized in Income (Ineffective Portion)
		Three Months Ended					Six Months Ended
Designated Cash Flow Hedges	Income Statement Location	July 2, 2016			June 27, 2015		July 2, 2016			June 27, 2015
Interest rate swap agreements	Other expense, net	$	—		$	—	$	(0.1	)	$	—
Foreign currency forward contracts	Net sales (restated)	(0.1		)	—		0.1			(0.3		)
	Cost of sales	(0.1		)	0.1		—			0.1
	Other expense, net (restated)	0.6			—		0.6			—
Total		$	0.4		$	0.1	$	0.6		$	(0.2	)

The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:



		Amount of Gain/(Loss) Recognized in Income
		Three Months Ended						Six Months Ended
Non-Designated Derivatives	Income Statement Location	July 2, 2016			June 27, 2015			July 2, 2016			June 27, 2015
Foreign currency forward contracts	Other expense, net	$	(1.6	)	$	5.2		$	(8.5	)	$	(250.5	)
	Interest expense, net	(0.6		)	(1.0		)	(0.5		)	(3.5		)
Total		$	(2.2	)	$	4.2		$	(9.0	)	$	(254.0	)